GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer
The post GLP-1 Receptor Agonists Show Promise Against Obesity Related Cancer appeared first on European Medical Journal .
Read the full articleYou might also wanna read
Two Observational Studies Link GLP-1 Receptor Agonists to Reduced Breast Cancer Risk in Women with Obesity
Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.
mdsc.pe·15d ago
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the future.
forbes.com·27d agoMedscape: GLP-1s Tied to Lower Cancer Risk in Patients With Obesity
The post Medscape: GLP-1s Tied to Lower Cancer Risk in Patients With Obesity appeared first on UNC Lineberger Comprehensive Cancer Center .
GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
Conditions : Alzheimer Disease; Diabetes Mellitus Type 2; Obesity & Overweight Interventions : Drug: GLP-1 Receptor Agonists; Drug: DPP-4 In
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption
Stronger safeguards are needed to ensure independent and transparent recommendations Glucagon-like peptide-1 (GLP-1) receptor agonists and r
bmj.com·21d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.